Improved activity and expression of recombinant human factor IX by propeptide engineering
Tóm tắt
The main therapeutic strategy for Hemophilia B patients involves the administration of recombinant coagulation factors IX (rFIX). Although there are various approaches to increasing the activity of rFIX, targeted protein engineering of specific residues could result in increased rFIX activity through enhanced γ-carboxylation. Specific amino acids in the propeptide sequence of vitamin K-dependent proteins are known to play a role in the interaction with the enzyme γ-carboxylase. The net hydrophobicity and charge of the γ-carboxylic recognition site (γ-CRS) region in the propeptide are important determinants of γ-carboxylase binding. So the contribution of individual γ-CRS residues to the expression of fully γ-carboxylated and active FIX was studied. Propeptide residues at positions −14, −13, or − 12 were substituted for equivalent prothrombin amino acids by SEOing PCR. The recombinant FIX variants were transfected and stably expressed in Drosophila S2 cells, and the expression of both total FIX protein and active FIX was assessed. While overall the substitutions resulted in an increase of both total FIX protein expression as well as an increase in the portion of active FIX, the highest increase in FIX protein expression, FIX activity, and specific FIX activity was observed following the simultaneous substitution of residues at positions −12, −13, and − 14. The enhanced rFIX activity was further confirmed by enrichment for functional, fully γ-carboxylated rFIX species via barium citrate adsorption. Our findings indicate that by increasing both the net charge and the net hydrophobicity of the FIX γ-CRS region, the expression of fully γ-carboxylated and as such active FIX is enhanced.
Tài liệu tham khảo
Roberts HR, Monroe D, Hoffman M. Molecular biology and biochemistry of the coagulation factors and pathways of hemostasis. Williams hematology. 2001;6:1409–34.
Pan LC, Price PA. The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors. Proc Natl Acad Sci. 1985;82:6109–13.
Stanley TB, Jin D-Y, Lin P-J, Stafford DW. The propeptides of the vitamin K-dependent proteins possess different affinities for the vitamin K-dependent carboxylase. J Biol Chem. 1999;274:16940–4.
Camire RM, Larson PJ, Stafford DW, High KA. Enhanced γ-carboxylation of recombinant factor X using a chimeric construct containing the prothrombin propeptide. Biochemistry. 2000;39:14322–9.
Wallin R, Hutson SM. Warfarin and the vitamin K-dependent γ-carboxylation system. Trends Mol Med. 2004;10:299–302.
Chu K, Wu S-M, Stanley T, Stafford DW, High KA. A mutation in the propeptide of factor IX leads to warfarin sensitivity by a novel mechanism. J Clin Invest. 1996;98:1619–25.
Jorgensen MJ, Cantor AB, Furie BC, Brown CL, Shoemaker CB, Furie B. Recognition site directing vitamin K-dependent γ-carboxylation resides on the propeptide of factor IX. Cell. 1987;48:185–91.
Huber P, Schmitz T, Griffin J, Jacobs M, Walsh C, Furie B, et al. Identification of amino acids in the gamma-carboxylation recognition site on the propeptide of prothrombin. J Biol Chem. 1990;265:12467–73.
Handford P, Winship P, Brownlee G. Protein engineering of the propeptide of human factor IX. Protein Eng. 1991;4:319–23.
Czerwiec E, Begley GS, Bronstein M, Stenflo J, Taylor K, Furie BC, et al. Expression and characterization of recombinant vitamin K-dependent γ-glutamyl carboxylase from an invertebrate, Conus textile. Eur J Biochem. 2002;269:6162–72.
Vermeer C. Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J. 1990;266:625–36.
Khorshidi S, Zomorodipour A, Behmanesh M, Vatandoost J, Bos MH. Functional expression of the human coagulation factor IX using heterologous signal peptide and propeptide sequences in mammalian cell line. Biotechnol Lett. 2015;37:1773–81. https://doi.org/10.1007/s10529-015-1868-3.
Vatandoost J, Hassankhani M. Effect of prepro-peptide replacement on γ-carboxylation and secretion of recombinant factor IX in Drosophila S2 cells. Iran J Pharm Res. 2018; in press.
Vatandoost J, Zarei Sani O. Effect of propeptide amino acid substitution in γ-carboxylation, activity and expression of recombinant human coagulation factor IX. Biotechnol Prog. 2018;34:515–20.
Rabiet M-J, Jorgensen MJ, Furie B, Furie BC. Effect of propeptide mutations on post-translational processing of factor IX. Evidence that beta-hydroxylation and gamma-carboxylation are independent events. J Biol Chem. 1987;262:14895–8.
Gasteiger E, Hoogland C, Gattiker A, Wilkins MR, Appel RD, Bairoch A. Protein identification and analysis tools on the ExPASy server. The proteomics protocols handbook. Springer; 2005. p. 571–607.
Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982;157:105–32.
Vatandoost J, Zomorodipour A, Sadeghizadeh M, Aliyari R, Bos MH, Ataei F. Expression of biologically active human clotting factor IX in Drosophila S2 cells: γ-carboxylation of a human vitamin K-dependent protein by the insect enzyme. Biotechnol Prog. 2012;28:45–51.
Cherbas L, Cherbas P. Transformation of Drosophila cell lines. Baculovirus and insect cell expression protocols. Springer; 2007. p. 317–40.
Vatandoost J, Bos MH. Efficient expression of functional human coagulation factor IX in stably transfected Drosophila melanogaster S2 cells; comparison with the mammalian CHO system. Biotechnol Lett. 2016;38:1691–8. https://doi.org/10.1007/s10529-016-2156-6.
Nilsen SL, Castellino FJ. Expression of human plasminogen inDrosophilaSchneider S2 cells. Protein Expr Purif. 1999;16:136–43.
Yao SN, Wilson JM, Nabel EG, Kurachi S, Hachiya HL, Kurachi K. Expression of human factor-ix in rat capillary endothelial-cells - toward somatic gene-therapy for hemophilia-b. Proc Natl Acad Sci U S A. 1991;88:8101–5.
Burns A, Olszowy P, Ciborowski P. Biomolecules. In: Ciborowski P, Silberring J, editors. Proteomic profiling and analytical chemistry. Second ed. Boston: Elsevier; 2016. p. 7–24.
Alberts B, Bray D, Hopkin K, Johnson A, Lewis J, Raff M et al. Chemical compound of cell Essential cell biology Garland Science; 2013. p. 55.
Czerwiec E, Kalume DE, Roepstorff P, Hambe B, Furie B, Furie BC, et al. Novel γ-carboxyglutamic acid-containing peptides from the venom of Conus textile. FEBS J. 2006;273:2779–88.
Foster DC, Rudinski MS, Schach BG, Berkner KL, Kumar AA, Hagen FS, et al. Propeptide of human protein C is necessary for. Gamma.-carboxylation. Biochemistry. 1987;26:7003–11.
Tröße C, Ravneberg H, Stern B, Pryme IF. Vectors encoding seven oikosin signal peptides transfected into CHO cells differ greatly in mediating Gaussia luciferase and human endostatin production although mRNA levels are largely unaffected. Gene Regul Syst Bio. 2007;1.
Knappskog S, Ravneberg H, Gjerdrum C, Tröβe C, Stern B, Pryme IF. The level of synthesis and secretion of Gaussia princeps luciferase in transfected CHO cells is heavily dependent on the choice of signal peptide. J Biotechnol. 2007;128:705–15.
Noriega TR, Tsai A, Elvekrog MM, Petrov A, Neher SB, Chen J, et al. Signal recognition particle-ribosome binding is sensitive to nascent-chain length. J Biol Chem. 2014;289:19294–305.
Mercier E, Holtkamp W, Rodnina MV, Wintermeyer W. Signal recognition particle binds to translating ribosomes before emergence of a signal anchor sequence. Nucleic Acids Res. 2017;45:11858–66.